Israeli Initiatives Seek to Sidestep Funding Crisis
|
|
- Dominic Long
- 5 years ago
- Views:
Transcription
1 Page 1 of 5 Feb (Vol. 29, No. 3) Feature Article Israeli Initiatives Seek to Sidestep Funding Crisis Dearth of Venture Capital Spawns Innovative Actions to Invigorate Country s Life Science Industry Vicki Glaser BioLineRx takes a different approach and in-licenses projects that are developed as independent projects under a single corporate structure. Regardless of the ambient economic climate which is, needless to say at the moment quite chilly obtaining funding to support a start-up biotech company and to commercialize an early-stage product or technology is difficult. The situation is not very different in Israel, despite an abundance of world-class academic and research institutions to serve as breeding grounds for cutting-edge therapeutic and diagnostic development programs, a history of successful endeavors across the high-tech spectrum, and the presence of pharmaceutical giant Teva Pharmaceuticals. The life science sector in Israel must contend with limited venture capital funds available to stimulate the growth of young biopharmaceutical companies. Even as Israel s economy and the focus of life science research have diversified, most venture capital firms with an interest in the biomedical industry continue to focus on the medical device sector. This dichotomy between an abundance of promising biomedical R&D and a dearth of funding sources has set the stage for some unique government-sponsored initiatives, regional programs, and a corporate-sponsored bioincubator aimed at fostering the expansion and financial success of start-up and existing biotech and biopharma ventures throughout the country. For the biotech industry, Israel is a country of opportunity and challenges, of wealth and need. The wealth of knowledge and academic research programs in Israel and the opportunity to commercialize cutting-edge discoveries stems from the country s innovative culture, says Elka Nir, managing director of life sciences at Giza VC. She points to the large number of patents that have emerged from basic R&D activities at institutions around the globe (Figure 1). The ongoing need in Israel is for development dollars. Key challenges for biopharma companies include location far from the largest market in the U.S. and a limited supply of professionals with management expertise and experience in starting and sustaining a biopharmaceutical company and taking a drug through clinical development and to the market. VC firms such as Giza try to fill some of these gaps by offering, not only early-stage financing, but also knowledge and experience, access to advisors, and help with business development and networking. Giza, for example, has an office in Singapore, which can assist young companies access the Asian market. It is easier if you have a presence in Asia to identify suppliers and help with regulatory issues and due diligence, says Nir. Giza introduced a preseed and seed-stage investment plan called the Ofek Program, a milestone-based plan in which the firm will invest no more than $500,000 in seed funding for early-stage projects being developed into commercial ventures in an incubator setting. As a project matures, if it meets established milestones, then Giza will invest additional funds. If it does not, then Giza can cut its losses. The Ofek Program also includes early investment-round funding to bring experienced entrepreneurs and managers in-house.
2 Page 2 of 5 Nir further reports that venture capital activity in the life sciences has been steadily increasing. Giza s investment in the life sciences is split about 70/30 for medical devices/drug development, which mirrors the overall VC picture in Israel, with approximately 60% of VC investments in the life sciences overall going toward the development of medical devices, according to the Israel Life Science Industry (ILSI), a group founded in 2005 that serves as an umbrella organization for the Israeli biotech industry. Currently, about 10 VC funds are active in the Israeli biotech sector. Eli Hazum, partner and chief scientist at Medica Venture Partners, agrees that the two main challenges young biotech companies face are the small amounts of seed funding available and the insufficient numbers of experienced managers and drug development teams, with Teva Pharmaceuticals being the only large company from which to draw seasoned professionals. We have the culture, says Hazum. It will take time, but we are on the right track, and the government is contributing. Hazum points out that Israeli investors in the life science sector are becoming increasingly sophisticated. They are looking for specialized pharma companies with innovative strategies such as novel drug delivery methods. Figure 1 Government Incentives Figure 2 According to ILSI, there are approximately 900 life science companies in Israel, with more than 70% founded within the last decade. The industry is heavily biased toward the medical device sector, with about 55% of companies focused in this area. The second largest sector (21%, or about 184 companies) is biotech, with pharmaceutical companies accounting for about 12% of all life science companies. Of the 184 biotech companies, 55 (30%) are revenue generating, with most selling diagnostic kits or research equipment. Another 64 companies (35% of the total) are in the seed stage, while 33 (18%) companies are in the preclinical drug development stage, and 20 (11%) are in clinical-stage development. There is increasing activity in the areas of tissue engineering and cell therapies. In 2007, the biotech sector was the recipient of about $66 million in venture capital funds, or about 4% of total VC financing in Israel. VC represents about 28% of the total financing for biotech R&D (Figure 2), according to ILSI. The majority of biotech financing comes from the Israeli government, which plays a key role in supporting entrepreneurship in general, and particularly in the high-tech sector. One way in which the government fosters high-tech R&D is through its support for a system of 23 technology incubators located throughout the country. Through the Office of the Chief Scientist (OCS) of the Ministry of Trade and Industry, the government offers grants to cover 85% of a start-up s approved R&D expenditures ($300,000 to $500,000) for two years. The scientists or project teams have to come up with the remaining 15%. If the effort is successful and results in a viable commercial venture, the company must repay the grant in the form of royalties on product sales. More recently, the government has encouraged the privatization of these incubators to increase involvement of private investors, and, to date, 12 of the existing incubators have been privatized. Once a product leaves an incubator it is subject to Israeli R&D restrictions: the intellectual property must remain in Israel and manufacturing has to be done in Israel. Opportunities for biopharma in Israel continue to expand as drug development success stories increase, and the government has recognized the unique needs of life science R&D compared to other high-tech industries and has responded with grants and incentives aimed at fostering the emergence and survival of fledgling drug development companies.
3 Page 3 of 5 Another government-funded mechanism, the TNUFA program, is intended to encourage technological entrepreneurship and innovation by providing economic and other forms of assistance to individual inventors and start-up companies during the preseed stage. This support may include assistance in evaluating a concept s technological and economic potential, patent proposal preparation, prototype construction, and business plan preparation, as well as help in attracting investors and establishing a relationship with an appropriate industry representative. Monetary grants may cover up to 85% of approved expenses, up to a maximum of $50,000 per project. To provide an incentive for private equity funds to invest in seed-stage companies, the Israeli government launched the Heznek Fund, which provides seed funding that must be matched by a private equity fund. To qualify for the Heznek program an R&D company must have been formed within the previous six months or have total expenditures of less than 800,000 Israel New Shekels (NIS; about $215,000), and not have already raised money from investors, except for primary financing to support feasibility studies. The government will invest up to 5 million NIS ($1.35 million) per company for two years, which can account for up to 50% of approved R&D expenses. In exchange for its investment, the government receives shares of the company. The private equity firm that put up the matching funds has the option to buy out the Heznek Fund s equity stake within the first five years, prior to any merger or acquisition. The government s Magnet Program targets generic R&D in an effort to mobilize private investment funds to support start-up ventures. It was established to provide a competitive position for Israel s industry with regard to state-of-the-art technologies of global interest, according to the OCS. R&D programs of a generic nature can qualify for Magnet funding if the company has been in existence for six months or less and has not incurred more than $250,000 in expenses. The government will invest no more than $1 million over two years to support up to 50% of a start-up company s approved program. The level of funding must be matched by venture capital financing, with both the government and the private investor receiving equity in the company. The private investor has the option to purchase the government s shares at the initial price any time within the first seven years, plus interest and cost-of-living increases. In addition to government funding available through technology incubators, the Heznek Fund, TNUFA, and the Magnet Program, start-up companies may seek seed funding available from Israel s venture capital industry, from foreign investors, or through a public offering on the Tel Aviv Stock Exchange. Incubators Recognizing that drug development is inherently more risky and requires longer timelines than medical device development, the Israeli government proposed establishing two specialized incubators solely for biotech-related R&D, with an increased funding ceiling ($1.8 million) and longer residence times (up to three years). Although this vision has not yet become a reality, one biotech incubator, BioLine Innovations Jerusalem, owned by BioLineRx, an Israeli clinical drug development company, was recognized by the government in 2004 as being essentially equivalent to what it had planned to create and received a special $23 million grant from the Ministry of Trade and Industry. Unlike a traditional incubator, in which a corporate structure is built around a drug or technology, BioLineRx takes a different approach and in-licenses projects that are developed as independent programs under a single corporate structure. Successful projects can be developed further by BioLineRx or licensed out. If a project is successful, the incubator pays the government back for that project; if it is not, BioLine shuts it down. We have created an incentive to fail unsuccessful projects early, says Morris Laster, M.D., CEO of
4 Page 4 of 5 BioLineRx, who has a history of successfully commercializing innovative technologies, having cofounded four publicly traded companies, including Keryx, XTL, and Neose Technologies. We don t believe in the need for a company for each project, Dr. Laster says. A company is a living thing, and as such is inherently driven to remain in existence, even when there is no longer justification for it to exist. Dr. Laster sees potential advantages of the BioLine Innovations incubator model for regional development of biotech outside of Israel as well, in areas that are research/academic-rich and investor-poor, such as the southeastern U.S., for example. BioLineRx was founded in 2003 through a joint effort of Teva Pharmaceuticals, Israeli venture capital firms Giza and Pitango, Hadasit (the technology transfer company of Hadassah Hospital), and the Jerusalem Development Authority (JDA). Focus on Jerusalem BioJerusalem is an economic initiative of the JDA, intended to boost development of the life science industry in the city by encouraging start-up ventures and the relocation or expansion of existing companies. In May 2008, the JDA began offering grants of 2.4 million NIS (about $617,000) to life science companies that establish a facility in Jerusalem, with the requirement that they hire at least 50 new employees and rent more than 2,500 square meters of space. Last fall, the program expanded to offer incentives amounting to 600,000 NIS ($154,240) for start-up companies that are less than six years of age and plan to hire at least three new employees and rent at least 50 square meters of space. Shirley Kutner, Ph.D., executive director of BioJerusalem, describes how the group works with universities, hospitals, medical schools, industry, and a variety of organizations to increase awareness of what the city has to offer, including a wealth of students, technology parks and incubators, and a sizable labor force. Dr. Kutner notes that 30% of all Israeli academic research is done in Jerusalem, as well as 43% of biotechnology research and 50% of clinical research. The city is home to the highest number of Ph.D. students in the life and biomedical sciences, and 35% of the country s biotech companies are there. While BioJerusalem cannot provide R&D funds, it can invest in companies by helping them pay municipal taxes and contributing to rent if company employees relocate to Jerusalem. For start-ups it can provide assistance in developing a business plan, make advisors available, and offer free management courses, forums, and networking opportunities. It can also invest in infrastructure needs in the city, including industrial parks such as the new BioMed Park at Ein-Kerem that houses only life science companies and is located near the campuses of Hebrew University Medical School and Hadassah Medical Center. Yissum, the technology transfer company of Hebrew University in Jerusalem, handles about 120 new projects each year, according to Nava Swersky-Sofer, president and CEO of Yissum. About 43% of total biotech research in Israel is done at Hebrew University, she says. Since its inception, Yissum has overseen about 6,000 patents and 1,800 projects. About 80% of these have involved licensing deals to existing companies, while 10 15% have formed the basis for start-up companies. Swerksy-Sofer points to clean technologies as an emerging area of interest, including water purification technology and biofuels. In December, Yissum launched a $1 million Cleantech Programme to support the development of cleantech inventions by scientists at HU. Hebrew University and its School of Agriculture are particularly strong in the area of agrobiotechnology. The vigorous hybrid seed industry in Israel emanated predominantly from research done at HU. Swersky-Sofer cites CollPlant, a biotech company housed in Weizmann Science Park, as an example of technology that emerged from research at HU.
5 Page 5 of 5 HOME SUBSCRIBE 2008 Genetic Engineering & Biotechnology News, All Rights Reserved - terms of use legal information privacy statement contact about GEN SITE MAP
2017 SRA International Annual Meeting. Dr. Eli Even, Head of Research Authority Bar-Ilan University, Israel
2017 SRA International Annual Meeting Dr. Eli Even, Head of Research Authority Bar-Ilan University, Israel October 14-18, 2017 PERSONAL INTRODUCTION PhD in Applied Chemistry, The Hebrew University, Jerusalem
More informationinnovationisrael.org.il Endless Possibilities to Promote Innovation
innovationisrael.org.il Endless Possibilities to Promote Innovation CONTENTS 4 Israel Innovation Authority Vision, goals and strategy Organizational structure For the benefit of entrepreneurs and companies
More informationDriving Jobs through Innovation:
Driving Jobs through Innovation: Fostering Science Entrepreneurship Priming Scientists into Entrepreneurs February 3, 2012 The is a product of Neworks, LLC www.neworks.biz 1 What Do Scientists Do? Research
More informationIsrael Advanced Technology Industries. Israel s Life Sciences Industry IATI 2015 Report
Israel Advanced Technology Industries Israel s Life Sciences Industry IATI 2015 Report Israel Advanced Technology Industries ISRAEL'S LARGEST UMBRELLA ORGANIZATION for the High-Tech and Life Science Industries
More informationStrategies for attracting healthcare venture capital
Beth Silverstein MS, RAC is the Director of SciLucent, LLC, a USbased management, regulatory and technical services consulting firm dedicated to helping healthcare product companies maximise the value
More informationAN OVERVIEW OF THE ISRAELI MEDICAL DEVICES INDUSTRY
The global healthcare systems are facing many challenges. Aging populations and burgeoning middle classes along with expectations of higher-quality care and a squeeze on funding have created a drive for
More informationIsrael : OCS Activity in the CleanTech Sectors
Israel : OCS Activity in the CleanTech Sectors Abraham Gross Deputy Chief Scientist, Ministry of Industry, Trade and Labor www.moital.gov.il/madan.htm Quality of Scientific Research Israel is a global
More informationMassachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry
Massachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry Massachusetts State Profile 5 Key Programs & Initiatives The opportunities generated by the biopharmaceutical sector as a leader
More informationDeveloping an Entrepreneurial Culture for Faculty, Researchers, and Students
Proceedings Teaching Entrepreneurship to Engineering Students Engineering Conferences International Year 2003 Developing an Entrepreneurial Culture for Faculty, Researchers, and Students Abigail Barrow
More informationVISION. Orange County will become a national and global leader in scalable innovation.
A P P L I E D I N N O V A T I O N VISION Orange County will become a national and global leader in scalable innovation. MISSION Startups UCI will be the UCI catalyst for innovation & entrepreneurship in
More informationStarTAU Tel Aviv University Entrepreneurship Center 1
StarTAU Tel Aviv University Entrepreneurship Center 1 Tel Aviv University Tel Aviv University (TAU), Founded in 1956, is the largest and most comprehensive institution of higher learning and research in
More informationRankings by World Economic Forum & International Institute for Management Development 1 st in the world for:
ISRAEL About Israel Israel is 65 years old Population of Israel: 8,134,100 Population of Arizona: 6,482,505 8,000 square miles could fit into Arizona 14 times Arable land used for farming: 15.45% - the
More informationThe Israeli Renewable Energy and Energy Efficiency Industry
The Israeli Renewable Energy and Energy Efficiency Industry Status update and policy recommendations for leveraging Israel s R&D and industry potential - EXECUTIVE SUMMARY - October 2015 Executive Summary
More informationFrom Science to Value. Introduction to VIB s tech transfer activities
From Science to Value Introduction to VIB s tech transfer activities VIB s mission Conduct frontline life sciences research Excellence in Science and Innovation Translate results into benefits for society
More informationBullpup Scientific. Technology & Product: Company at a Glance: Goals
Bullpup Scientific www.bullpupscientific.com Category: Medical Devices Sub-category: Medical Equipment, Disposable & Implantable Therapeutic Area(s): ICU - Intensive Care unit Company Status: Initial Revenues
More informationAlfred E. Mann Foundation for Biomedical Engineering
Alfred E. Mann Foundation for Biomedical Engineering Venture Philanthropy and Directed Philanthropy as a New Mode of Capitalization to Move University Scientific and Technological Research to the Marketplace
More informationPaper on Business Incubator Framework
HIGHER EDUCATION H-9, Islamabad (Pakistan) Phone :(051) 90400000 Paper on Business Incubator Framework 1 Table of Contents Background 3 Advantages of Academic Affiliated incubator 4 Incubator Structure
More informationAppendix II: U.S. Israel Science and Technology Collaboration 2028
Appendix II: U.S. Israel Science and Technology Collaboration 2028 "Israel 2028: Vision and Strategy for Economy and Society in a Global World, initiated and sponsored by the U.S.-Israel Science and Technology
More informationINNOVATION AND TECHNOLOGY IN A BRICS COUNTRY CASE OF SOUTH AFRICAN ENTERPRISES
INNOVATION AND TECHNOLOGY IN A BRICS COUNTRY CASE OF SOUTH AFRICAN ENTERPRISES 1 Smita Kuriakose, The World Bank Investigating Industrial and Innovation Policies for Growth: Contrasting Expert s Views
More informationTechnion Technology Transfer Connecting Partners to Find Solutions
Technion Technology Transfer Connecting Partners to Find Solutions 2016 http://blog.compass.co/the-2015-global-startup-ecosystem-ranking-is-live The Global Startup Ecosystem Ranking 2015 Israeli Venture
More informationModels for Innovation
Models for Innovation Moderator: Larry Stofko, EVP The Innovation Institute DISCLAIMER: The views and opinions expressed in this presentation are those of the author and do not necessarily represent official
More informationEquity-Free Investments: Annual ~$2.5B Small Business Innovation Research and Small Business Technology Transfer Programs
Equity-Free Investments: Annual ~$2.5B Small Business Innovation Research and Small Business Technology Transfer Programs March 14, 2018 Ms. Pat Dillon, MBA 2 Mission MN-SBIR provides outreach, education
More informationMaryland Technology Enterprise Institute
Maryland Technology Enterprise Institute web: www.mtech.umd.edu tel: (301) 405-3906 fax: (301) 403-4105 Educate, Create, Connect Maryland Technology Enterprise Institute The mission of Mtech is to: Educate
More informationEnterprise Fellowships:
Enterprise Fellowships: Training and support for founders Applicant guidance notes 2018 Stage 1 deadline: 1 September 2018 Stage 2 deadline: 1 October 2018 Introduction Enterprise Fellowships Our Enterprise
More informationNarrative Descriptions of Sessions Day One Submission, Policy, Procedures
Narrative Descriptions of Sessions Day One Submission, Policy, Procedures Overview and Update of the NIH SBIR and STTR Programs The NIH SBIR and STTR programs offer many opportunities for small companies
More informationED28.1. MaRS Discovery. District. Yung Wu CEO. Cory Mulvihill Lead Executive, Policy & Public Affairs. MaRS OVERVIEW / 1
MaRS Discovery ED28.1 2018 District Yung Wu CEO Cory Mulvihill Lead Executive, Policy & Public Affairs MaRS OVERVIEW / 1 TORONTO AS A HUB FOR CANADA S CONVERGENT INNOVATION Strongest Patenting and VC Investment
More informationI 2 Program Frequently Asked Questions
I 2 Program Frequently Asked Questions What is the Genome BC Industry Innovation (I 2 ) Program? The I 2 Program offers repayable growth capital to businesses (with less than 500 employees), commercializing
More informationthe center for advancing innovation
the center for advancing innovation BREAST CANCER STARTUP CHALLENGE OVERVIEW Discussion Document: July 6, 2009 Partnership between the National Cancer Institute, the Office of Technology Transfer, the
More informationThe Michigan Initiative for Innovation & Entrepreneurship A consortium of public universities for transforming practice and culture
The Michigan Initiative for Innovation & Entrepreneurship A consortium of public universities for transforming practice and culture Overview Many leaders and institutions across the state of Michigan have
More informationU.S.-Israel Joint Economic Development Group R&D Mapping Project
U.S.-Israel Joint Economic Development Group R&D Mapping Project I. Introduction EXECUTIVE SUMMARY The U.S. and Israeli technology and innovation enterprises are deeply intertwined. Leading U.S. firms
More informationOur mission. University of Washington Evolving to Meet Faculty Needs. Universities Contribute to Building Wealthy Regions. Building Wealthy Regions
Our mission University of Washington Evolving to Meet Faculty Needs To extend the impact of University of Washington research through the creation of partnerships that encourage investment in innovation
More informationINCENTIVES AND SUPPORT SYSTEMS TO FOSTER PRIVATE SECTOR INNOVATION. Jerry Sheehan. Introduction
INCENTIVES AND SUPPORT SYSTEMS TO FOSTER PRIVATE SECTOR INNOVATION Jerry Sheehan Introduction Governments in many countries are devoting increased attention to bolstering business innovation capabilities.
More informationKorean Academy of Science and Technology
Korean Academy of Science and Technology November 20, 2003 Presentation by Thomas F. George, Ph.D. Chancellor and Professor of Chemistry & Physics University of Missouri-St. Louis I. Evolution of Academic
More informationInnovation and Prosperity
Islamic Republic of Iran Presidency Innovation and Prosperity Fund An Overview of Iran s Innovation and Prosperity Fund for Startups Key Trends of Iran s STI in a glimpse *Unctad Report,2016 Key Trends
More informationVIRGINIA-ISRAEL BIOSCIENCES COMMERCIALIZATION CENTER
VIRGINIA-ISRAEL BIOSCIENCES COMMERCIALIZATION CENTER Jan Youtie Summary The Virginia-Israel Biosciences Commercialization Center is an international soft landings initiative in Richmond, Virginia. The
More informationCrossing the Valley of Death
Crossing the Valley of Death The Small Business Innovation Research Program Technology Caucus Washington, DC December 3, 2013 Charles W. Wessner, Ph.D. Director, Technology, Innovation, and Entrepreneurship
More informationPublic Private Partnership: Building Innovation Ecosystem
Public Private Partnership: Building Innovation Ecosystem Anya Eldan Vice President Israel Innovation Authority innovationisrael.org.il Major impact on the Israeli economy 9% of Employees 15% of GDP 50%
More informationSourcing Innovation From the Migration of Companies To, From and Between Emerging Markets
Sourcing Innovation From the Migration of Companies To, From and Between Emerging Markets Tom Sweeney CEO & Managing Director STEM 7 Capital Partners Ltd Big Trend: The Globalization of the Commercialization
More informationR E Q U E S T F O R A P P L I C A T I O N S
R E Q U E S T F O R A P P L I C A T I O N S RFA C-12-INCU-2 Texas Life Science Incubator Infrastructure Awards 2011 2012 Fiscal Year Award Period September 1, 2011 August 31, 2012 CPRIT RFA C-12-INCU-2
More informationCOLUMBIA UNIVERSITY COLUMBIA BUSINESS SCHOOL EXECUTIVE MBA PROGRAM LAUNCHING NEW VENTURES B7519. Friday and Saturday Summer 2014
COLUMBIA UNIVERSITY COLUMBIA BUSINESS SCHOOL EXECUTIVE MBA PROGRAM LAUNCHING NEW VENTURES B7519 Friday and Saturday Summer 2014 PROFESSOR JACK M. KAPLAN Course assistant Jeff Friedman OFFICE TELEPHONE:
More informationThe Wesley Clover Company Development Model
Building Businesses The Wesley Clover Company Development Model Managing Risks while Developing Tech Companies for Global Markets 2015 1 The information and images contained in this presentation may not
More informationPrograms & Initiatives Advancing the Biopharmaceutical Industry
Pennsylvania Programs & Initiatives Advancing the Biopharmaceutical Industry Pennsylvania State Profile 1 Key Programs & Initiatives The opportunities generated by the biopharmaceutical sector as a leader
More informationINNOVATION IN RUSSIA: POTENTIAL, CHALLENGES & DRIVERS
INNOVATION IN RUSSIA: POTENTIAL, CHALLENGES & DRIVERS MYRON WASYLYK, CEO, PBN HILL+KNOWLTON STRATEGIES 11 NOVEMBER 2016 METHODOLOGY Online Survey & Expert Interviews October November 2016 60+ companies
More information2. Entrepreneurs possess highly specialized behavioral attributes that are distinct from those of non-entrepreneurs. (False)
Questions for Chapter 2 True/False 1. Entrepreneurship is a process that can be learned. 2. Entrepreneurs possess highly specialized behavioral attributes that are distinct from those of non-entrepreneurs.
More informationUS Startup Outlook 2018
US STARTUP OUTLOOK 2018 1 US Startup Outlook 2018 A Silicon Valley Bank survey of US entrepreneurs about business conditions and policy priorities LETTER FROM SVB CEO US STARTUP OUTLOOK 2018 2 Startups
More informationChapter 02 Sources of Innovation
Chapter 02 Sources of Innovation True/False 1. Sometimes knowing a field too well can stifle creativity. Page: 19 2. The organization s structure, routines, and incentives can thwart individual creativity,
More informationThe Knowledge Strategy of Israel
The Knowledge Strategy of Israel Dr. Edna Pasher Second Austrian Conference on Knowledge and Politics 2010 About our group Israeli Management consulting and research group (since 1978) Introduced KM to
More informationTechnology Driven Enterprise & Economic Development. for the BECC
Technology Driven Enterprise & Economic Development for the BECC by L. (Marty) Murphy Manager, NREL Enterprise Development Program Nov. 17, 2008. Sacramento, CA 1 Public Private Partnerships - Going Beyond
More informationHow to increase national absorptive capacity for green technology
How to increase national absorptive capacity for green technology MichikoENOMOTO -UNECE- Bishkek, 7 November 2012 Some introductory questions 1. If 50 major firms with promising innovative green technologies
More informationEstimating the Economic Contributions of the Utah Science Technology and Research Initiative (USTAR) to the Utah Economy
Estimating the Economic Contributions of the Utah Science Technology and Research Initiative (USTAR) to the Utah Economy Prepared for The Utah Science and Research Governing Authority Prepared by Jan Elise
More informationMediwales Finance and Funding Event:
Mediwales Finance and Funding Event: Cardiff, March 22 nd 2012 Translational Research Funding for Companies Dr Tim Knott Business Development Manager, Technology Transfer The Wellcome Trust Overview of
More informationUMass Lowell New Venture Initiative (NVI) Program Summary
UMass Lowell New Venture Initiative (NVI) Program Summary The University of Massachusetts Lowell has a well-established history as an innovative research institution that contributes to the economic growth
More informationState of Life Sciences Entrepreneurship in Louisiana
State of Life Sciences Entrepreneurship in Louisiana We at Baker Donelson and LouisianaBIO are pleased to present this report on the state of life science entrepreneurship in Louisiana. This report offers
More informationCanadian Accelerators
Canadian Accelerators Company Focus Conditions Description Sherbrooke,QC Innovative firms and/or start-up technologies Cash investment up to $20,000, professional services in kind, and 5% equity investment
More informationUSTAR INDUSTRY PARTNERSHIPS PROGRAM (IPP) FY17 PROGRAM ANNOUNCEMENT
USTAR INDUSTRY PARTNERSHIPS PROGRAM (IPP) FY17 PROGRAM ANNOUNCEMENT UTAH SCIENCE TECHNOLOGY AND RESEARCH (USTAR) INITIATIVE USTAR is the State of Utah s technology catalyst, accelerating the growth of
More informationONTARIO S FIRST CHIEF SCIENCE OFFICER
ONTARIO S FIRST CHIEF SCIENCE OFFICER FEEDBACK SUBMISSION 3/22/2017 OBIO 2017 Ontario s First Chief Science Officer The Honourable Reza Moridi Minister of Research, Innovation and Science 12 th Floor,
More informationThe Role of the Research Enterprise in Economic Development
The Role of the Research Enterprise in Economic Development Board of Trustees Workgroup Research and Health Sciences April 17, 2008 Karen A. Holbrook Vice President for Research and Innovation Science
More informationPrograms & Initiatives Advancing the Biopharmaceutical Industry
Tennessee Programs & Initiatives Advancing the Biopharmaceutical Industry Tennessee State Profile 1 Key Programs & Initiatives The opportunities generated by the biopharmaceutical sector as a leader in
More informationencouraging investment
Iris Stark, CPA island of stability Against the background of uncertainty created by the global financial and economic crisis, Israel is still an island of stability. It has come through the crisis without
More informationISRAEL Case Study of an Ecosystem StartUps and Innovation. Dr Laura Altschuler
ISRAEL Case Study of an Ecosystem StartUps and Innovation Dr Laura Altschuler All rights reserved to DUO IDB 2018 BEFORE INTERCONNECTION Network Carrier Constrained point-to-point connectivity, backhauling
More informationBusiness Incubation in Academia
Business Incubation in Academia Experiences at IIT Bombay Poyni Bhatt SINE, IIT Bombay, India for infodev Asia and the Pacific Regional Workshop 2007 4.10.2007 Overview Incubation at IIT Bombay: Introduction
More informationGuidelines for FLoW DOE Cleantech UP Applicants
Guidelines for FLoW DOE Cleantech UP Applicants 2016-2017 Prizes: FLoW DOE Cleantech UP prize: $50,000; FLoW Prizes: $125,000; Transformational Idea Award: $5,000. Scope: The competition s scope ranges
More informationCanada s Innovation and Skills Plan
Canada s Innovation and Skills Plan Source: Pratt & Whitney Canada Building a prosperous and innovative Canada Canada s Strong Foundations for Innovation TOP TALENT 2 nd in the Global Entrepreneurship
More informationBritish Columbia Innovation Council 2016/ /19 SERVICE PLAN
2016/17 2018/19 SERVICE PLAN For more information on the British Columbia Innovation Council contact: 9th floor - 1188 West Georgia Street Vancouver, BC V6E 4A2 Phone: 604-683-2724 Toll free: 1-800-665-7222
More informationThe Activities and Roles of M.I.T. in Forming Clusters and Strengthening Entrepreneurship
CHAPTER 3.13 The Activities and Roles of M.I.T. in Forming Clusters and Strengthening Entrepreneurship LITA NELSEN, Director, M.I.T. Technology Licensing Office, U.S.A. ABSTRACT This chapter describes
More informationCOUNTRY PROFILE. Israel
COUNTRY PROFILE Israel Statistical tables Factor I: Economic Performance WORLD COMPETITIVENESS RANKING 18 All data are available from the World Competitiveness Online. Visit our eshop 1 COMPETITIVENESS
More informationBusiness Globalization
EMC 2 Global Innovation Conference Santa Clara, CA, October 31, 2012 Business Globalization and the Importance of Entrepreneurial Innovation Richard B. Dasher, Ph.D. Director, US-Asia Technology Management
More informationVirginia Tech. Capturing the Value of Technology Transfer. January 24, Virginia Tech Intellectual Properties
Virginia Tech Capturing the Value of Technology Transfer January 24, 2008 VISION Technology Transfer Benefits Society ewisjosia@aol.com MISSION Imagine the Possibilities Foster commercial investment in
More informationMaryland Technology Enterprise Institute
Maryland Technology Enterprise Institute web: www.mtech.umd.edu tel: (301) 405-3906 fax: (301) 403-4105 Educate, Create, Connect Maryland Technology Enterprise Institute The mission of Mtech is to: Educate
More informationStarting Your Own Business: The Entrepreneurship Alternative
Starting Your Own Business: The Entrepreneurship Alternative www.wileybusinessupdates.com Chapter Six Copyright 2015 John Wiley & Sons, Inc. Learning Objectives 2 1 2 Define entrepreneur Identify the different
More informationVIEWPOINT. Chasing Innovation: R&D Barriers and Incentives in China.
The American Chamber of Commerce in Shanghai - Viewpoint April 2018 www.amcham-shanghai.org Chasing Innovation: R&D Barriers and Incentives in China 2018 The 52 respondent companies vary significantly
More informationRaising the Odds of Success for Tech Transfer. Jay Schrankler September 17, 2010
Raising the Odds of Success for Tech Transfer Jay Schrankler September 17, 2010 How to define success-return based, cash based or fundraising based? -Going public or filing to go public positive ROI for
More informationHow Technology-Based Start-Ups Support U.S. Economic Growth
How Technology-Based Start-Ups Support U.S. Economic Growth BY J. JOHN WU AND ROBERT D. ATKINSON NOVEMBER 2017 Policymakers should focus on spurring highgrowth, technologybased start-ups. These firms,
More informationHEAR MORE AT A FREE ANGELS AND GOVERNMENT FUNDING SEMINAR
We have answered the call from small business clients! With over 1200 funding opportunities available to businesses in Australia, this guide is designed to break those down and help you find the right
More informationOctober 22, MTC Overview
October 22, 2015 MTC Overview About MTC Public-private partnership created by the Missouri General Assembly to lead efforts to promote entrepreneurship and foster the growth of new and emerging high-tech
More informationZakariah Abdul Rashid
Malaysian Institute of Economic Research (MIER) Zakariah Abdul Rashid The views expressed in this paper/presentation are the views of the author and do not necessarily reflect the views or policies of
More informationThe New Carolina Initiative
The New Carolina Initiative Professor Michael E. Porter Harvard Business School New Carolina Annual Celebration September 22, 2011 For further material on regional competitiveness and clusters: www.isc.hbs.edu/econ-clusters.htm
More informationUSTAR TECHNOLOGY ENTREPREUNERSHIP SERVICES. Ivy Estabrooke, PhD Executive Director
USTAR TECHNOLOGY ENTREPREUNERSHIP SERVICES Ivy Estabrooke, PhD Executive Director iestabrooke@utah.gov USTAR VISION AND MISSION Utah Vision: Utah will lead the nation as the best performing economy, and
More information28/02/2011. Encouragement for Industrial R&D In Israel STATE OF ISRAEL MINISTRY OF INDUSTRY AND TRADE OFFICE OF THE CHIEF SCIENTIST
Page 1 of 18 Encouragement for Industrial R&D In Israel STATE OF ISRAEL MINISTRY OF INDUSTRY AND TRADE OFFICE OF THE CHIEF SCIENTIST ENCOURAGEMENT FOR INDUSTRIAL R&D IN ISRAEL Update: January 2001. Dear
More informationValuation Strategies. Larry O. Blankenship Evergreen Research, Inc.
Valuation Strategies Larry O. Blankenship Evergreen Research, Inc. February, 2015 Many Levels, Many Approaches Seed, early stage and pre-revenue valuation is different than mezzanine or growth funding
More informationKickStart Venture Services Commercialization Award Program
KickStart Venture Services Commercialization Award Program Request for Applications Description The KickStart Venture Services Commercialization Award Program will provide up to $50K in non-dilutive funding
More informationLife Sciences Tax Incentive Program
Life Sciences Tax Incentive Program Solicitation No. 2017 TAX-01 Program Manager: Cheryl Sadeli, Vice President of Finance Questions: Taxprogram@masslifesciences.com Solicitation Issued: December 4, 2017
More informationLOW-CARBON INNOVATION FUND (LCIF) Program Guidelines
LOW-CARBON INNOVATION FUND (LCIF) 2017-18 Program Guidelines What is the Low-Carbon Innovation Fund? The Low-Carbon Innovation Fund (LCIF) is a discretionary, non-entitlement granting program administered
More informationEuropean Investment Fund in Support of Tech Transfer
European Investment Fund European Investment Fund in Support of Tech Transfer This presentation was prepared by EIF. Any estimates and projections contained herein involve significant elements of subjective
More informationConnecting Startups to VC Funding in Canada
Technology & Life sciences Connecting Startups to VC Funding in Canada introduction While the majority of respondents have accessed early seed investment from friends, family and angel investors, many
More informationThe Ultimate Guide to Startup Success:
The Ultimate Guide to Startup Success: Launching a startup is an exciting prospect, but one that is also fraught with considerable challenges. Bringing a new idea to the marketplace requires more than
More informationVote for BC. Vote for Tech.
Vote for BC. Vote for Tech. Advancing the tech sector is a part of each party s agenda. Here s a summary of key tech-related elements in the three platforms as it relates to BCTECH s policy pillars: talent,
More informationMassachusetts Institute of Technology. Energy MIT. October 21, Summary of Discussion *
Massachusetts Institute of Technology PRESIDENT S ADVISORY COUNCIL ON REGIONAL ENGAGEMENT Energy Summit @ MIT SCALING UP THE REGION S CLEAN ENERGY INDUSTRY October 21, 2010 Summary of Discussion * I. Overview
More informationBusiness Environment and Knowledge for Private Sector Growth: Setting the Stage
Business Environment and Knowledge for Private Sector Growth: Setting the Stage Fernando Montes-Negret Sector Director Private and Financial Sector Development Department, Europe and Central Asia (ECA)
More informationForward-Looking Statements
Forward-Looking Statements This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks,
More informationEvaluation of the Israeli Technological Incubator Program and Its Projects
SNI Shefer - Frenkel Evaluation of the Israeli Technological Incubator Program and Its Projects Evaluation of the Israeli Technological Incubator Program and Its Projects Daniel Shefer Amnon Frenkel 1
More informationFinancial Support Business Start Ups and Growth Companies. September 2011
Financial Support Business Start Ups and Growth Companies September 2011 1 1 2 Our Role Financial Support Agenda 3 Other Support 4 Access Support 2 Irish owned enterprise Policy analysis and advice Inward
More informationImplementing Economic Policy for Innovation and Entrepreneurship: The Mexican Case. Lorenza Martinez April, 2012
Implementing Economic Policy for Innovation and Entrepreneurship: The Mexican Case Lorenza Martinez April, 2012 1 Mexican economic development strategy based on fostering productivity 1 The projections
More informationUS Startup Outlook Key insights from the Silicon Valley Bank Startup Outlook Survey
US Startup Outlook 2018 Key insights from the Silicon Valley Bank Startup Outlook Survey LETTER FROM SVB CEO US STARTUP OUTLOOK 2018 2 Startups enter 2018 with confidence For the ninth year, Silicon Valley
More informationInnovation Academy. Business skills courses for Imperial Entrepreneurs
INNOVATION ACADEMY Innovation Academy Business skills courses for Imperial Entrepreneurs Innovation Academy Business skills courses for Imperial entrepreneurs Imperial Innovations has launched Innovation
More informationEmory and Georgia Tech:
Emory and Georgia Tech: Making Atlanta a hot spot in the innovation economy James Wagner, President Emory University Wayne Clough, President Georgia Tech Metro Atlanta Chamber of Commerce May 18, 2006
More informationOFFICIAL RULES & GUIDELINES
OFFICIAL RULES & GUIDELINES ENTRY GUIDELINES PURPOSE OF PROGRAM To encourage the founding of high-potential new ventures and to reward the developers of promising business plans. ELIGIBILITY Team Size
More informationBUSINESS INCUBATION TRAINING PROGRAM
+ INNOVATION & ENTREPRENEURSHIP BUSINESS INCUBATION TRAINING PROGRAM Training Program Overview THE WORLD BANK www.infodev.org INTRODUCTION TO THE TRAINING PROGRAM infodev (www.infodev.org) is a research,
More informationEXECUTIVE EDUCATION in Life Sciences
EXECUTIVE EDUCATION in Life Sciences Growing future leaders in Pharma and Biotech Educational agreement: CONTENTS 02 03 A note from Juan The Institute Student Profile Educational Model Faculty and Board
More informationTABLE OF CONTENTS FOR TECHNOLOGY TRANSFER AND RESEARCH COMMITTEE
TABLE OF CONTENTS FOR TECHNOLOGY TRANSFER AND RESEARCH COMMITTEE Committee Meeting: 5/14/2014 Board Meeting: 5/15/2014 Austin, Texas Wallace L. Hall, Jr., Chairman Ernest Aliseda Alex M. Cranberg R. Steven
More information